Synergy Pharma (SGYP) Files $250M Mixed Shelf
Tweet Send to a Friend
Up)
Synergy Pharmaceuticals, Inc. (Nasdaq: SGYP) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $250 million of Common Stock, Preferred Stock, Warrants, Units, or any combination thereof.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Synergy Pharmaceuticals Added to NASDAQ Biotechnology Index
- VIVUS (VVUS) Prices $220M Convertible Debt Offering
- Cyclacel Pharmaceuticals (CYCC) Announces Stock Offering
Create E-mail Alert Related Categories
Equity Offerings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
